Assertio Holdings, Inc. financial data

Symbol
ASRT on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 S. Saunders Road, Suite 300, Lake Forest, Illinois
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Assertio Therapeutics, Inc (to 5/10/2019), DEPOMED INC (to 5/26/2016), DEPOMED INC (to 5/26/2016)
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 174 % +35.3%
Quick Ratio 36.3 % +156%
Debt-to-equity 88.1 % -11.2%
Return On Equity -185 % -453%
Return On Assets -98.4 % -473%
Operating Margin -178 % -987%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 95M shares +70.9%
Common Stock, Shares, Outstanding 95.1M shares +70.9%
Entity Public Float 296M USD +111%
Common Stock, Value, Issued 9K USD +80%
Weighted Average Number of Shares Outstanding, Basic 95M shares +86.2%
Weighted Average Number of Shares Outstanding, Diluted 95M shares +86.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 142M USD -12.4%
Research and Development Expense 3.58M USD
Costs and Expenses 395M USD +204%
Operating Income (Loss) -253M USD -877%
Nonoperating Income (Expense) -321K USD +98.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -253M USD -1701%
Income Tax Expense (Benefit) 80.1M USD
Net Income (Loss) Attributable to Parent -333M USD -443%
Earnings Per Share, Basic -4.65 USD/shares -326%
Earnings Per Share, Diluted -4.65 USD/shares -364%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 80.7M USD +17.7%
Accounts Receivable, after Allowance for Credit Loss, Current 42.6M USD -8.3%
Inventory, Net 38.6M USD +138%
Other Assets, Current 297K USD
Assets, Current 172M USD +25.1%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 704K USD +29.4%
Operating Lease, Right-of-Use Asset 1.23M USD +1053%
Intangible Assets, Net (Excluding Goodwill) 106M USD -44.9%
Goodwill 19.9M USD
Other Assets, Noncurrent 3.09M USD +18.7%
Assets 282M USD -31.9%
Accounts Payable, Current 15.7M USD +154%
Employee-related Liabilities, Current 1.45M USD +141%
Accrued Liabilities, Current 15.4M USD +42.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 92.4M USD -2.22%
Operating Lease, Liability, Noncurrent 1.35M USD +3.85%
Other Liabilities, Noncurrent 16.4M USD +280%
Liabilities 147M USD -9.86%
Retained Earnings (Accumulated Deficit) -656M USD -103%
Stockholders' Equity Attributable to Parent 134M USD -46.3%
Liabilities and Equity 282M USD -31.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.51M USD -67%
Net Cash Provided by (Used in) Financing Activities -206K USD +98.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 95.1M shares +70.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.3M USD +99.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 80.7M USD +17.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.3M USD -44.7%
Deferred Tax Assets, Valuation Allowance 316M USD +2427%
Deferred Tax Assets, Gross 317M USD +200%
Operating Lease, Liability 2.15M USD +602%
Depreciation 600K USD -25%
Payments to Acquire Property, Plant, and Equipment 628K USD +129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -333M USD -443%
Lessee, Operating Lease, Liability, to be Paid 2.83M USD +571%
Property, Plant and Equipment, Gross 5.4M USD +15.6%
Operating Lease, Liability, Current 797K USD +160%
Lessee, Operating Lease, Liability, to be Paid, Year Two 412K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.07M USD +155%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -45%
Deferred Income Tax Expense (Benefit) 76.2M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 428K USD +2040%
Lessee, Operating Lease, Liability, to be Paid, Year Three 307K USD
Deferred Tax Assets, Operating Loss Carryforwards 245M USD +260%
Deferred Federal Income Tax Expense (Benefit) 62.9M USD
Current Income Tax Expense (Benefit) 1.69M USD -12%
Unrecognized Tax Benefits 7.74M USD +88.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 243K USD
Operating Lease, Payments 895K USD -42.5%
Additional Paid in Capital 791M USD +37.8%
Current State and Local Tax Expense (Benefit) 858K USD -3.92%
Current Federal Tax Expense (Benefit) 829K USD -19%
Amortization of Intangible Assets 26.9M USD -11.6%
Depreciation, Depletion and Amortization 5.7M USD -12.2%
Deferred Tax Assets, Net of Valuation Allowance 367K USD -99.6%
Deferred State and Local Income Tax Expense (Benefit) 13.3M USD
Interest Expense 6.76M USD -31.5%